Anaveon
Laetitia Petersen is a senior scientist at Anaveon, a company that specializes in developing drugs for rare diseases. Laetitia previously worked at Roche as a scientist from September 2006 to December 2019.
Laetitia Petersen studied specialisation in Biotechnologie at Université catholique de Lyon.
They are on a team with Daniela Di Blasi - Clinical Scientist, Pia Neubert - Associate Scientist, and Alexander Rau - Scientist, Protein Engineering. Their manager is Christoph Huber, Chief Scientific Officer.
This person is not in any offices
Anaveon
1 followers
Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.